Cargando…

Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure

Background: Wearable cardioverter-defibrillators (WCDs) are a well-established tool to bridge the recovery time of left ventricular ejection fraction (LVEF) until the implantation of an implantable cardioverter defibrillator (ICD), as recommended by the current guidelines. Besides their function to...

Descripción completa

Detalles Bibliográficos
Autores principales: Blockhaus, Christian, Guelker, Jan-Erik, Feyen, Ludger, Bufe, Alexander, Seyfarth, Melchior, Shin, Dong-In
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224944/
https://www.ncbi.nlm.nih.gov/pubmed/35735804
http://dx.doi.org/10.3390/jcdd9060175
_version_ 1784733494967009280
author Blockhaus, Christian
Guelker, Jan-Erik
Feyen, Ludger
Bufe, Alexander
Seyfarth, Melchior
Shin, Dong-In
author_facet Blockhaus, Christian
Guelker, Jan-Erik
Feyen, Ludger
Bufe, Alexander
Seyfarth, Melchior
Shin, Dong-In
author_sort Blockhaus, Christian
collection PubMed
description Background: Wearable cardioverter-defibrillators (WCDs) are a well-established tool to bridge the recovery time of left ventricular ejection fraction (LVEF) until the implantation of an implantable cardioverter defibrillator (ICD), as recommended by the current guidelines. Besides their function to detect and treat malignant arrhythmias, WCDs may be used as a telemonitoring system. In this study, we sought to illustrate and discuss the telemonitoring potential of WCDs and to analyze physical activity in specific patient cohorts. Methods and Results: We retrospectively included 140 patients with reduced LVEF who were prescribed WCDs in our clinic. We analyzed the patients’ physical activity (n = 105 with a WCD compliance above 21 h/day), body position and resting position. We found a reduced physical activity in women and in patients over the age of 65 compared to younger patients. Furthermore, the patients who were overweight or obese showed significantly reduced physical activity compared to the patients with a normal weight (6365 ± 3572 vs. 4972 ± 2476 vs. 7045 ± 3521, p = 0.02). Conclusion: WCDs may be used as a telemonitoring and intervention tool in patients with reduced LVEF. Specific patient groups may benefit from guidance from their treating physician regarding physical activity.
format Online
Article
Text
id pubmed-9224944
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92249442022-06-24 Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure Blockhaus, Christian Guelker, Jan-Erik Feyen, Ludger Bufe, Alexander Seyfarth, Melchior Shin, Dong-In J Cardiovasc Dev Dis Article Background: Wearable cardioverter-defibrillators (WCDs) are a well-established tool to bridge the recovery time of left ventricular ejection fraction (LVEF) until the implantation of an implantable cardioverter defibrillator (ICD), as recommended by the current guidelines. Besides their function to detect and treat malignant arrhythmias, WCDs may be used as a telemonitoring system. In this study, we sought to illustrate and discuss the telemonitoring potential of WCDs and to analyze physical activity in specific patient cohorts. Methods and Results: We retrospectively included 140 patients with reduced LVEF who were prescribed WCDs in our clinic. We analyzed the patients’ physical activity (n = 105 with a WCD compliance above 21 h/day), body position and resting position. We found a reduced physical activity in women and in patients over the age of 65 compared to younger patients. Furthermore, the patients who were overweight or obese showed significantly reduced physical activity compared to the patients with a normal weight (6365 ± 3572 vs. 4972 ± 2476 vs. 7045 ± 3521, p = 0.02). Conclusion: WCDs may be used as a telemonitoring and intervention tool in patients with reduced LVEF. Specific patient groups may benefit from guidance from their treating physician regarding physical activity. MDPI 2022-06-01 /pmc/articles/PMC9224944/ /pubmed/35735804 http://dx.doi.org/10.3390/jcdd9060175 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Blockhaus, Christian
Guelker, Jan-Erik
Feyen, Ludger
Bufe, Alexander
Seyfarth, Melchior
Shin, Dong-In
Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure
title Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure
title_full Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure
title_fullStr Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure
title_full_unstemmed Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure
title_short Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure
title_sort telemonitoring potential of wearable cardioverter-defibrillators during the follow-up of patients with heart failure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224944/
https://www.ncbi.nlm.nih.gov/pubmed/35735804
http://dx.doi.org/10.3390/jcdd9060175
work_keys_str_mv AT blockhauschristian telemonitoringpotentialofwearablecardioverterdefibrillatorsduringthefollowupofpatientswithheartfailure
AT guelkerjanerik telemonitoringpotentialofwearablecardioverterdefibrillatorsduringthefollowupofpatientswithheartfailure
AT feyenludger telemonitoringpotentialofwearablecardioverterdefibrillatorsduringthefollowupofpatientswithheartfailure
AT bufealexander telemonitoringpotentialofwearablecardioverterdefibrillatorsduringthefollowupofpatientswithheartfailure
AT seyfarthmelchior telemonitoringpotentialofwearablecardioverterdefibrillatorsduringthefollowupofpatientswithheartfailure
AT shindongin telemonitoringpotentialofwearablecardioverterdefibrillatorsduringthefollowupofpatientswithheartfailure